Eligibility and prescribing of low-dose aspirin for preeclampsia prevention under two international guidelines: a retrospective cohort study.

Authors

Nimet Alyörük Geçici, Fatma Nazlı Demir, Yeliz Acar Sabır, Harun Karaağaç, Sefa Öztürk, Umutcan Kayıkçı

Published in

Journal of perinatal medicine. Oct 20, 2026. Epub Oct 20, 2026.

Abstract

The primary objective was to compare eligibility for low-dose aspirin prophylaxis according to the American College of Obstetricians and Gynecologists (ACOG) and the National Institute for Health and Care Excellence (NICE) recommendations. Secondary objectives were to evaluate aspirin prescribing among eligible women and preeclampsia outcomes according to guideline eligibility.
This retrospective cohort study included 1,064 pregnant women with complete clinical data from a tertiary referral hospital in Türkiye. Eligibility was determined according to ACOG and NICE criteria. Agreement was assessed using Cohen's kappa and McNemar's test. Aspirin prescribing and preeclampsia outcomes were also evaluated.
According to the ACOG criteria, 311 women (29.23 %, 95 % CI, 26.58-32.03 %) were eligible for aspirin prophylaxis, whereas 130 (12.22 %, 95 % CI, 10.39-14.32 %) met the NICE criteria. The overall agreement between the two guidelines was 82.9 %, with moderate concordance (Cohen's kappa=0.50). McNemar's test demonstrated a significant difference in patient classification (p<0.001). Aspirin was prescribed to only 25.4 % of ACOG-eligible women and 48.5 % of NICE-eligible women. Overall, preeclampsia occurred in 38 of 1,064 women (3.57 %; 95 % CI, 2.61-4.86 %). Among women eligible for aspirin prophylaxis, preeclampsia developed in 23 of 311 women (7.4 %; 95 % CI, 4.98-10.85 %) according to ACOG criteria and in 16 of 130 women (12.3 %; 95 % CI, 7.72-19.06 %) according to NICE criteria.
Although the ACOG guideline identified substantially more women as eligible for aspirin prophylaxis than the NICE guideline, documented aspirin prescribing remained considerably lower than guideline-defined eligibility, highlighting an implementation gap in routine clinical practice.

PMID:
42895106
Bibliographic data and abstract were imported from PubMed on 19 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.